Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.
Read More…
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone844-428-2667
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$652.30 million
Profitability
Miscellaneous
Employees4,700
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable
Avanos Medical (NYSE:AVNS) Frequently Asked Questions
What is Avanos Medical's stock symbol?
Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."
How were Avanos Medical's earnings last quarter?
Avanos Medical Inc (NYSE:AVNS) released its earnings results on Tuesday, August, 6th. The company reported $0.28 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.25 by $0.03. The firm earned $172.20 million during the quarter, compared to analysts' expectations of $172.02 million. Avanos Medical had a negative net margin of 3.92% and a positive return on equity of 4.18%. Avanos Medical's revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.20 EPS. View Avanos Medical's Earnings History.
When is Avanos Medical's next earnings date?
What guidance has Avanos Medical issued on next quarter's earnings?
Avanos Medical updated its FY19 earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of $1.15-1.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.23.
What price target have analysts set for AVNS?
6 brokers have issued 12 month price targets for Avanos Medical's stock. Their predictions range from $45.00 to $65.00. On average, they expect Avanos Medical's share price to reach $51.25 in the next year. This suggests a possible upside of 31.4% from the stock's current price. View Analyst Price Targets for Avanos Medical.
What is the consensus analysts' recommendation for Avanos Medical?
6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 2 sell ratings, 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.
Has Avanos Medical been receiving favorable news coverage?
News headlines about AVNS stock have been trending neutral recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Avanos Medical earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Avanos Medical.
Who are some of Avanos Medical's key competitors?
Some companies that are related to Avanos Medical include DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), Invacare (IVC), RTI Surgical (RTIX), ConforMIS (CFMS), Lakeland Industries (LAKE), Histogenics (HSGX), Rewalk Robotics (RWLK), Precision Therapeutics (POAI), COLLPLANT HOLDI/S (CLGN) and NanoVibronix (NAOV).
What other stocks do shareholders of Avanos Medical own?
Who are Avanos Medical's key executives?
Avanos Medical's management team includes the folowing people:
- Mr. Joseph F. Woody, CEO & Director (Age 53)
- Mr. John W. Wesley, Sr. VP of Legal & Gov. Relations (Age 60)
- Mr. John R. Tushar, Pres of Global Franchises (Age 57)
- Mr. Arjun Ranjan Sarker, Sr. VP of International (Age 53)
- Mr. Warren J. MacHan, Sr. VP of Bus. Strategy & Interim CFO (Age 53)
Who are Avanos Medical's major shareholders?
Avanos Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Confluence Investment Management LLC (0.29%), Pacer Advisors Inc. (0.04%), State of Alaska Department of Revenue (0.02%), Gateway Investment Advisers LLC (0.02%) and North Star Investment Management Corp. (0.01%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.
Which institutional investors are selling Avanos Medical stock?
Which institutional investors are buying Avanos Medical stock?
AVNS stock was bought by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, State of Alaska Department of Revenue and North Star Investment Management Corp.. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.
How do I buy shares of Avanos Medical?
Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Avanos Medical's stock price today?
One share of AVNS stock can currently be purchased for approximately $39.00.
How big of a company is Avanos Medical?
Avanos Medical has a market capitalization of $1.86 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.
What is Avanos Medical's official website?
How can I contact Avanos Medical?
Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]
MarketBeat Community Rating for Avanos Medical (NYSE AVNS)
MarketBeat's community ratings are surveys of what our community members think about Avanos Medical and other stocks. Vote "Outperform" if you believe AVNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
